News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Biotech Bay
23andMe, Inc. to Hold Press Meeting at World Economic Forum Annual Meeting in Davos, Switzerland on Wednesday, January 23rd, 2008
January 18, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--23andMe, Inc., a privately-held personal genetics company, announced today that it will be holding a press meeting at this year’s World Economic Forum in Davos:
Twitter
LinkedIn
Facebook
Email
Print
Events
23andMe
MORE ON THIS TOPIC
Podcast
Sentiment at BIO soars as FDA resets, dealmaking evolves; Amgen’s Tavneos in hot water
July 1, 2026
·
2 min read
·
Jef Akst
China
BIO outshines World Cup as biotech celebrates 50th anniversary with a ‘call to action’
June 30, 2026
·
4 min read
·
Annalee Armstrong
Mergers & acquisitions
BIO 2026: Forget dual track—biopharma deals are more complex than ever
June 25, 2026
·
5 min read
·
Annalee Armstrong
Pancreatic cancer
Revolution’s second RAS blocker doubles chemo response rate in pancreatic cancer
June 25, 2026
·
2 min read
·
Tristan Manalac